Tovetumab Biosimilar – Anti-PDGFRA , PDGFR2, CD140a mAb – Research Grade

Reference:
Size

,

Isotype

IgG2, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameTovetumab Biosimilar - Anti-PDGFRA , PDGFR2, CD140a mAb - Research Grade
SourceCAS 1243266-04-7
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsTovetumab,MEDI-575,PDGFRA , PDGFR2, CD140a,anti-PDGFRA , PDGFR2, CD140a
ReferencePX-TA1328
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody

Description of Tovetumab Biosimilar - Anti-PDGFRA , PDGFR2, CD140a mAb - Research Grade

General information on Anti-PDGFRA / PDGFR2/ CD140a[Homo sapiens] (Tovetumab) Monoclonal Antibody

Tovetumab has been investigated for the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Tovetumab Biosimilar – Anti-PDGFRA , PDGFR2, CD140a mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Platelet Derived Growth Factor proteins Receptor Alpha
Antigen

Platelet Derived Growth Factor proteins Receptor Alpha

PX-P5106 420€
Tovetumab ELISA Kit
ELISA

Tovetumab ELISA Kit

KPTX194 1300€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products